| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79 | 102 | 80 | 101 | 103 | 114 | 138 | 162 | 171 | 175 | 180 | 192 | |
Growth YoY Revenue Growth YoY% | 30.9 | 11.5 | 71.7 | 60.8 | 65.9 | 53.4 | 30.6 | 18.9 | ||||
| 64 | 80 | 59 | 77 | 77 | 95 | 104 | 112 | 121 | 128 | 126 | 135 | |
| 15 | 22 | 21 | 23 | 26 | 19 | 34 | 50 | 50 | 47 | 54 | 58 | |
OPM OPM% | 19.3 | 21.9 | 26.5 | 23.1 | 24.9 | 17.0 | 24.8 | 30.6 | 29.5 | 27.1 | 29.8 | 30.0 |
| 1 | 2 | 0 | 2 | 5 | 12 | 3 | 13 | 7 | 18 | 3 | 9 | |
Interest Expense Interest ExpenseCr | 2 | 3 | 5 | 5 | 6 | 5 | 5 | 6 | 5 | 8 | 7 | 9 |
Depreciation DepreciationCr | 3 | 4 | 4 | 4 | 4 | 5 | 6 | 8 | 8 | 9 | 10 | 10 |
PBT PBTCr | 10 | 18 | 13 | 16 | 20 | 21 | 26 | 41 | 45 | 47 | 39 | 48 |
| 3 | 3 | 3 | 3 | 4 | 3 | 5 | 11 | 11 | 11 | 9 | 11 | |
| 7 | 14 | 11 | 13 | 16 | 18 | 21 | 30 | 34 | 37 | 30 | 37 | |
Growth YoY PAT Growth YoY% | 131.1 | 26.7 | 94.1 | 130.4 | 104.4 | 104.1 | 43.8 | 21.5 | ||||
NPM NPM% | 9.0 | 13.8 | 13.6 | 13.0 | 15.9 | 15.7 | 15.3 | 18.6 | 19.6 | 20.9 | 16.9 | 19.0 |
| 4.0 | 8.0 | 3.4 | 3.9 | 5.0 | 3.8 | 4.6 | 6.5 | 7.3 | 8.0 | 6.6 | 8.8 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79 | 102 | 80 | 101 | 103 | 114 | 138 | 162 | 171 | 175 | 180 | 192 | |
Growth YoY Revenue Growth YoY% | 30.9 | 11.5 | 71.7 | 60.8 | 65.9 | 53.4 | 30.6 | 18.9 | ||||
| 64 | 80 | 59 | 77 | 77 | 95 | 104 | 112 | 121 | 128 | 126 | 135 | |
| 15 | 22 | 21 | 23 | 26 | 19 | 34 | 50 | 50 | 47 | 54 | 58 | |
OPM OPM% | 19.3 | 21.9 | 26.5 | 23.1 | 24.9 | 17.0 | 24.8 | 30.6 | 29.5 | 27.1 | 29.8 | 30.0 |
| 1 | 2 | 0 | 2 | 5 | 12 | 3 | 13 | 7 | 18 | 3 | 9 | |
Interest Expense Interest ExpenseCr | 2 | 3 | 5 | 5 | 6 | 5 | 5 | 6 | 5 | 8 | 7 | 9 |
Depreciation DepreciationCr | 3 | 4 | 4 | 4 | 4 | 5 | 6 | 8 | 8 | 9 | 10 | 10 |
PBT PBTCr | 10 | 18 | 13 | 16 | 20 | 21 | 26 | 41 | 45 | 47 | 39 | 48 |
| 3 | 3 | 3 | 3 | 4 | 3 | 5 | 11 | 11 | 11 | 9 | 11 | |
| 7 | 14 | 11 | 13 | 16 | 18 | 21 | 30 | 34 | 37 | 30 | 37 | |
Growth YoY PAT Growth YoY% | 131.1 | 26.7 | 94.1 | 130.4 | 104.4 | 104.1 | 43.8 | 21.5 | ||||
NPM NPM% | 9.0 | 13.8 | 13.6 | 13.0 | 15.9 | 15.7 | 15.3 | 18.6 | 19.6 | 20.9 | 16.9 | 19.0 |
| 4.0 | 8.0 | 3.4 | 3.9 | 5.0 | 3.8 | 4.6 | 6.5 | 7.3 | 8.0 | 6.6 | 8.8 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
Revenue RevenueCr | 14 | 35 | 215 | 398 | 633 | 719 |
Growth Revenue Growth% | 149.4 | 507.1 | 85.7 | 58.9 | 39.0 | |
| 12 | 23 | 173 | 309 | 464 | 509 | |
| 2 | 13 | 42 | 90 | 168 | 209 | |
OPM OPM% | 13.8 | 35.9 | 19.4 | 22.5 | 26.6 | 29.1 |
| 0 | 4 | 3 | 19 | 47 | 37 | |
Interest Expense Interest ExpenseCr | 1 | 2 | 9 | 22 | 25 | 30 |
Depreciation DepreciationCr | 1 | 2 | 10 | 17 | 31 | 37 |
PBT PBTCr | 1 | 12 | 25 | 71 | 159 | 179 |
| 0 | 4 | -8 | 12 | 38 | 42 | |
PAT PATCr | 1 | 8 | 33 | 58 | 122 | 137 |
Growth PAT Growth% | 751.0 | 287.9 | 78.4 | 108.3 | 60.2 | |
NPM NPM% | 7.0 | 23.9 | 15.3 | 14.7 | 19.2 | 19.1 |
| 1.8 | 8.9 | 13.7 | 16.1 | 26.4 | 30.7 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
Revenue RevenueCr | 14 | 35 | 215 | 398 | 633 | 719 |
Growth Revenue Growth% | 149.4 | 507.1 | 85.7 | 58.9 | 39.0 | |
| 12 | 23 | 173 | 309 | 464 | 509 | |
| 2 | 13 | 42 | 90 | 168 | 209 | |
OPM OPM% | 13.8 | 35.9 | 19.4 | 22.5 | 26.6 | 29.1 |
| 0 | 4 | 3 | 19 | 47 | 37 | |
Interest Expense Interest ExpenseCr | 1 | 2 | 9 | 22 | 25 | 30 |
Depreciation DepreciationCr | 1 | 2 | 10 | 17 | 31 | 37 |
PBT PBTCr | 1 | 12 | 25 | 71 | 159 | 179 |
| 0 | 4 | -8 | 12 | 38 | 42 | |
PAT PATCr | 1 | 8 | 33 | 58 | 122 | 137 |
Growth PAT Growth% | 751.0 | 287.9 | 78.4 | 108.3 | 60.2 | |
NPM NPM% | 7.0 | 23.9 | 15.3 | 14.7 | 19.2 | 19.1 |
| 1.8 | 8.9 | 13.7 | 16.1 | 26.4 | 30.7 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 9 | 10 | 31 | 46 | 46 | 46 |
Reserves ReservesCr | 28 | 36 | 174 | 740 | 887 | 957 |
| 10 | 52 | 248 | 241 | 424 | 412 | |
| 13 | 34 | 143 | 174 | 215 | 237 | |
| 59 | 131 | 622 | 1,227 | 1,604 | 1,681 | |
| 27 | 51 | 251 | 722 | 812 | 766 | |
| 32 | 80 | 371 | 504 | 791 | 914 | |
| 59 | 131 | 622 | 1,227 | 1,604 | 1,681 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 9 | 10 | 31 | 46 | 46 | 46 |
Reserves ReservesCr | 28 | 36 | 174 | 740 | 887 | 957 |
| 10 | 52 | 248 | 241 | 424 | 412 | |
| 13 | 34 | 143 | 174 | 215 | 237 | |
| 59 | 131 | 622 | 1,227 | 1,604 | 1,681 | |
| 27 | 51 | 251 | 722 | 812 | 766 | |
| 32 | 80 | 371 | 504 | 791 | 914 | |
| 59 | 131 | 622 | 1,227 | 1,604 | 1,681 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| -10 | -1 | -26 | -46 | 62 | |
| -24 | -48 | -54 | -429 | -121 | |
| 36 | 46 | 87 | 573 | -1 | |
Net Cash Flow Net Cash FlowCr | 2 | -3 | 7 | 98 | -60 |
Free Cash Flow Free Cash FlowCr | -21 | -48 | -78 | -203 | -203 |
CFO To PAT CFO To PAT% | -1,054.2 | -12.8 | -78.6 | -78.7 | 51.1 |
CFO To EBITDA CFO To EBITDA% | -535.2 | -8.5 | -61.8 | -51.2 | 36.9 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| -10 | -1 | -26 | -46 | 62 | |
| -24 | -48 | -54 | -429 | -121 | |
| 36 | 46 | 87 | 573 | -1 | |
Net Cash Flow Net Cash FlowCr | 2 | -3 | 7 | 98 | -60 |
Free Cash Flow Free Cash FlowCr | -21 | -48 | -78 | -203 | -203 |
CFO To PAT CFO To PAT% | -1,054.2 | -12.8 | -78.6 | -78.7 | 51.1 |
CFO To EBITDA CFO To EBITDA% | -535.2 | -8.5 | -61.8 | -51.2 | 36.9 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 2,638 | 3,490 | 5,024 | |||
Price To Earnings Price To Earnings | 45.0 | 30.3 | 35.5 | |||
Price To Sales Price To Sales | 6.6 | 5.5 | 7.0 | |||
Price To Book Price To Book | 3.4 | 3.7 | 5.0 | |||
EV To EBITDA EV To EBITDA | 28.6 | 21.8 | 25.5 | |||
GPM GPM% | 43.0 | 63.7 | 44.0 | 44.3 | 53.1 | 53.1 |
OPM OPM% | 13.8 | 35.9 | 19.4 | 22.5 | 26.6 | 29.1 |
NPM NPM% | 7.0 | 23.9 | 15.3 | 14.7 | 19.2 | 19.1 |
ROCE ROCE% | 3.3 | 13.5 | 7.5 | 8.4 | 14.4 | 14.9 |
ROE ROE% | 2.7 | 18.5 | 16.0 | 7.4 | 13.0 | 13.7 |
ROA ROA% | 1.7 | 6.4 | 5.3 | 4.8 | 7.6 | 8.2 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 2,638 | 3,490 | 5,024 | |||
Price To Earnings Price To Earnings | 45.0 | 30.3 | 35.5 | |||
Price To Sales Price To Sales | 6.6 | 5.5 | 7.0 | |||
Price To Book Price To Book | 3.4 | 3.7 | 5.0 | |||
EV To EBITDA EV To EBITDA | 28.6 | 21.8 | 25.5 | |||
GPM GPM% | 43.0 | 63.7 | 44.0 | 44.3 | 53.1 | 53.1 |
OPM OPM% | 13.8 | 35.9 | 19.4 | 22.5 | 26.6 | 29.1 |
NPM NPM% | 7.0 | 23.9 | 15.3 | 14.7 | 19.2 | 19.1 |
ROCE ROCE% | 3.3 | 13.5 | 7.5 | 8.4 | 14.4 | 14.9 |
ROE ROE% | 2.7 | 18.5 | 16.0 | 7.4 | 13.0 | 13.7 |
ROA ROA% | 1.7 | 6.4 | 5.3 | 4.8 | 7.6 | 8.2 |
| Market CapitalizationMkt CapCr | 7,612 | 6,814 | 6,147 | 5,024 | 4,284 | 4,202 | 4,194 |
| Close PriceClose₹ | 269.40 | 640.55 | 377.55 | 1,090.80 | 4,128.40 | 2,540.90 | 418.25 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 42.09 | 19.62 | 35.52 | 44.67 | 37.91 | 52.41 | |
| Price To SalesPS | 836.51 | 6.34 | 2.69 | 6.99 | 6.86 | 5.50 | 4.06 |
| RevenueRevenueCr | 9 | 1,074 | 2,289 | 719 | 624 | 764 | 1,032 |
| Revenue Growth TTMRev Gr TTM% | 55.0% | 24.9% | 10.2% | 39.0% | 47.7% | 14.7% | 18.2% |
| PAT Growth TTMPAT Gr TTM% | -80.3% | 44.3% | 39.0% | 60.2% | 95.7% | -48.5% | 40.7% |
| Market CapitalizationMkt CapCr | 7,612 | 6,814 | 6,147 | 5,024 | 4,284 | 4,202 | 4,194 |
| Close PriceClose₹ | 269.40 | 640.55 | 377.55 | 1,090.80 | 4,128.40 | 2,540.90 | 418.25 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 42.09 | 19.62 | 35.52 | 44.67 | 37.91 | 52.41 | |
| Price To SalesPS | 836.51 | 6.34 | 2.69 | 6.99 | 6.86 | 5.50 | 4.06 |
| RevenueRevenueCr | 9 | 1,074 | 2,289 | 719 | 624 | 764 | 1,032 |
| Revenue Growth TTMRev Gr TTM% | 55.0% | 24.9% | 10.2% | 39.0% | 47.7% | 14.7% | 18.2% |
| PAT Growth TTMPAT Gr TTM% | -80.3% | 44.3% | 39.0% | 60.2% | 95.7% | -48.5% | 40.7% |